Amerisource Cuts $625M FCA Deal Over Repacked Drugs
Pharmaceutical giant AmerisourceBergen Corp. has struck a $625 million deal to settle the government's False Claims Act investigation into the drug wholesaler's practice of repackaging and selling injectable drugs, allegedly without...To view the full article, register now.
Already a subscriber? Click here to view full article